Skip to main content
Equibles
OMDA logo

OMDA · Omada Health, Inc. · Metrics

Track OMDA — free

Use OMDA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OMDA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.95 -0.03 (-0.16%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$1.16B
Shares
61.22M
Volume · Oct 23 678.15K Avg daily vol (3M) 1.38M

OMDA metrics

91 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$18.95
Market cap
$1.16B

Price action

20 metrics
Price change (1W)
+7.5%
Price change (30D)
-3.9%
Price change (3M)
-7.7%
Price change (6M)
+32.2%
Price change (YTD)
+20.1%
Price change (1Y)
-26.2%
Trailing year
Price change (5Y)
—
52-week high
$26.78
52-week low
$10.94
Change from 52-week high
-29.2%
Change from 52-week low
+73.2%
Annualized volatility
62.8%
Annualized volatility (3M)
72.5%
Beta
1.3
RSI (14D)
44.1
Price vs SMA 50
-10.7%
Price vs SMA 200
+7.6%
Avg volume (3M)
1.38M
Relative volume
0.5
Average dollar volume
$29.33M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
61.22M

Valuation

12 metrics
P / E (TTM)
17.7
Trailing earnings · reciprocal yield 5.6%
PEG ratio
—
EV / revenue
3.0×
reciprocal yield 32.9%
EV / EBITDA
173.1×
reciprocal yield 0.6%
EV / EBIT
—
P / sales
3.8×
reciprocal yield 26.7%
P / book
4.6
reciprocal yield 21.8%
FCF yield
2.0%
TTM · current market cap
Buyback yield
—
P / FCF
51.1
reciprocal yield 2.0%
P / operating cash flow
49.1
reciprocal yield 2.0%
Earnings yield
0.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
68.2%
Operating margin
-0.1%
Trailing 12 months
Net margin
1.4%
Gross profit (TTM)
$211.21M
Operating profit (TTM)
−$464,000
Net income (TTM)
$4.30M
Trailing 12 months
Diluted EPS (TTM)
$1.07
FCF margin
7.3%
Effective tax rate
0.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$5.19
Gross profit per diluted share (TTM)
$3.53
Operating profit per diluted share (TTM)
$-0.01
EBITDA per diluted share (TTM)
$0.09
Net income per diluted share (TTM)
$0.07
Operating cash flow per diluted share (TTM)
$0.41
Free cash flow per diluted share (TTM)
$0.39
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
$0.82
Stock compensation per diluted share (TTM)
$0.29
Book value per share
$3.93

Growth

11 metrics
Revenue growth YoY
+43.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$309.76M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+191.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
1.7%
Return on assets
1.3%
Debt / equity
0.0
Current ratio
3.9
EBITDA (TTM)
$5.43M
Free cash flow (TTM)
$22.73M
Quick ratio
3.9
Interest coverage
-1.2
Net debt / EBITDA
-40.8
Return on invested capital
-1.5%
Trailing 12 months
Net cash
$221.71M
Latest balance sheet
Cash & equivalents
$221.71M
Total assets
$328.22M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$23.68M
Capital expenditures (TTM)
$960,000
R&D (TTM)
$49.17M
SG&A (TTM)
—
Stock compensation (TTM)
$17.12M
R&D / revenue
15.9%
Stock compensation / revenue
5.5%

Ownership (13F)

9 metrics
13F filers
153
13F filer change QoQ
+13
Institutional ownership
89.6%
Conviction holders (share of 13F filers)
3.9%
Crowding (high-turnover and private-fund holders)
40.7%
Private-fund adviser ownership
36.2%
Active holders' share change QoQ
+6.4%
Holder tenure
3.6
Price vs estimated holder cost
+32.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
7.1%

Short interest

3 metrics
Short interest
12.2%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
73 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$2.93M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1611115 CUSIP 68170A108 13F (30d) 25 filings 25 filers Visit website Investor relations